Malvern Panalytical has launched a collaboration with Small Angle X-ray Scattering specialists Xenocs to explore how complementary analytical solutions will give you deeper insights into the structural features of your biopharmaceuticals.
Join our biophysical characterization and biopharmaceutical experts to dive into applications around nucleic acid drug products (such as mRNA vaccines and RNA therapeutics), as well as biopharmaceuticals, including peptide-based therapeutics.
Full calendar
📅 23rd October 2024: Key tools for understanding drug efficacy and stability
📅 20th November 2024: Complementary techniques for biophysical characterization of peptides and protein-based drug products
📅 10th December 2024: Elucidating the internal structure of RNA-based therapeutics and vaccines
Key tools for understanding drug efficacy and stability
23rd October 2024
Join Dr Hanna Hanna Jankevics-Jones (Malvern Panalytical) and Dr Soren Skou (Xenocs Nordic) as they share their insights on biophysical characterization methods. Discover how applying techniques in complementary, and orthogonal ways, provides additional insight on biopharmaceutical substances, helping shape their properties and routes to formulations.
Complementary techniques for biophysical characterization of peptides and protein-based drug products
20th November 2024
Learn how Novo Nordisk is using Dynamic Light Scattering (DLS), Small Angle X-ray Scattering (SAXS) and Size-Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS) to gain deeper insights into peptide population distribution and agglomeration behavior.
Elucidating the internal structure of RNA-based therapeutics and vaccines
10th December 2024
Discover how advanced techniques like Differential Scanning Calorimetry (DSC) and Small Angle X-ray Scattering (SAXS) complement traditional methods such as DLS and ELS. Learn how these tools reveal critical particle structure insights, detect changes under stress, and explore nanoscale details without extensive sample preparation.